Theratechnologies Statistics
Total Valuation
THTX has a market cap or net worth of $79.98 million. The enterprise value is $97.80 million.
Important Dates
The next estimated earnings date is Wednesday, February 19, 2025, before market open.
| Earnings Date | Feb 19, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
THTX has 45.98 million shares outstanding. The number of shares has increased by 87.34% in one year.
| Current Share Class | 45.98M |
| Shares Outstanding | 45.98M |
| Shares Change (YoY) | +87.34% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 34.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 0.93 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.16 |
| EV / EBITDA | 6.79 |
| EV / EBIT | 8.23 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.08
| Current Ratio | 1.08 |
| Quick Ratio | 0.94 |
| Debt / Equity | n/a |
| Debt / EBITDA | 3.93 |
| Debt / FCF | n/a |
| Interest Coverage | 1.01 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | 11.76% |
| Return on Capital (ROIC) | 27.17% |
| Revenue Per Employee | $818,602 |
| Profits Per Employee | -$30,660 |
| Employee Count | 103 |
| Asset Turnover | 1.33 |
| Inventory Turnover | 3.06 |
Taxes
In the past 12 months, THTX has paid $1.06 million in taxes.
| Income Tax | 1.06M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.88% in the last 52 weeks. The beta is 1.73, so THTX's price volatility has been higher than the market average.
| Beta (5Y) | 1.73 |
| 52-Week Price Change | +11.88% |
| 50-Day Moving Average | 1.33 |
| 200-Day Moving Average | 1.33 |
| Relative Strength Index (RSI) | 68.22 |
| Average Volume (20 Days) | 129,811 |
Short Selling Information
The latest short interest is 43,799, so 0.10% of the outstanding shares have been sold short.
| Short Interest | 43,799 |
| Short Previous Month | 78,213 |
| Short % of Shares Out | 0.10% |
| Short % of Float | 0.13% |
| Short Ratio (days to cover) | 1.48 |
Income Statement
In the last 12 months, THTX had revenue of $84.32 million and -$3.16 million in losses. Loss per share was -$0.07.
| Revenue | 84.32M |
| Gross Profit | 64.90M |
| Operating Income | 11.89M |
| Pretax Income | -6.57M |
| Net Income | -3.16M |
| EBITDA | 14.40M |
| EBIT | 11.89M |
| Loss Per Share | -$0.07 |
Full Income StatementBalance Sheet
The company has $38.86 million in cash and $57.83 million in debt, giving a net cash position of -$18.98 million or -$0.41 per share.
| Cash & Cash Equivalents | 38.86M |
| Total Debt | 57.83M |
| Net Cash | -18.98M |
| Net Cash Per Share | -$0.41 |
| Equity (Book Value) | -19.68M |
| Book Value Per Share | -0.43 |
| Working Capital | 4.35M |
Full Balance SheetCash Flow
| Operating Cash Flow | -1.50M |
| Capital Expenditures | n/a |
| Free Cash Flow | -1.50M |
| FCF Per Share | -$0.03 |
Full Cash Flow StatementMargins
Gross margin is 76.97%, with operating and profit margins of 14.10% and -3.75%.
| Gross Margin | 76.97% |
| Operating Margin | 14.10% |
| Pretax Margin | -2.49% |
| Profit Margin | -3.75% |
| EBITDA Margin | 17.08% |
| EBIT Margin | 14.10% |
| FCF Margin | n/a |